← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mitotherapeutix, Llc
Cheshire, CT
$2,978,400
Total funding
4
Grants
Funding over time
peak $1.3M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,978,400 · 4
By mechanism
R44$2,122,291 · 1
R41$856,109 · 3
Investigators at Mitotherapeutix, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A novel approach to treat non-alcoholic steatohepatitis (NASH)$1,008,980
R44 · FY2023 · DK
A novel approach to treat non-alcoholic steatohepatitis (NASH)$860,261
R44 · FY2022 · DK
A novel approach to treat non-alcoholic steatohepatitis (NASH)$317,953
R41 · FY2017 · DK
Novel Treatment for Alcohol-associated Liver Disease$273,918
R41 · FY2023 · AA
A Novel Treatment for Acetominophen-Induced Liver Injury$264,238
R41 · FY2018 · DK
A novel approach to treat non-alcoholic steatohepatitis (NASH)$253,050
R44 · FY2021 · DK